Introduction: Hydrophobic tagging (HyT) technology presents a distinct therapeutic strategy diverging from conventional small molecule drugs, providing an innovative approach to drug design. This review aims to provide an overview of the HyT literature and future outlook to offer guidance for drug design.
Areas Covered: In this review, the authors introduce the composition, mechanisms and advantages of HyT technology, as well as summarize the detailed applications of HyT technology in anti-cancer, neurodegenerative diseases (NDs), autoimmune disorders, cardiovascular diseases (CVDs), and other fields. Furthermore, this review discusses key aspects of the future development of HyT molecules.
Expert Opinion: HyT emerges as a highly promising targeted protein degradation (TPD) strategy, following the successful development of proteolysis targeting chimeras (PROTAC) and molecular glue. Based on exploring new avenues, modification of the HyT molecule itself potentially enhances the technology. Improved synthetic pathways and emphasis on pharmacokinetic (PK) properties will facilitate the development of HyT. Furthermore, elucidating the biochemical basis by which the compound's hydrophobic moiety recruits the protein homeostasis network will enable the development of more precise assays that can guide the optimization of the linker and hydrophobic moiety.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/17460441.2024.2360416 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Half of Atlantic reef-building corals at elevated risk of extinction due to climate change and other threats.
PLoS One
November 2024
University of Oxford, Oxford, United Kingdom.
Article Synopsis
- Atlantic reef-building corals are declining due to climate change, disease, pollution, and human activities, prompting a reassessment of their extinction risk under the IUCN Red List.
- The latest evaluation shows an increase in the percentage of species at high extinction risk, with nearly 46% to 54% of shallow water corals now classified as threatened, compared to 15% to 40% in 2008.
- Although there's been a slight improvement in coral coverage over historical data, projections indicate that severe bleaching events could significantly threaten the future survival of 26 species, which are now labeled as Critically Endangered.
Overview of class I HDAC modulators: Inhibitors and degraders.
Eur J Med Chem
October 2024
Department of Pharmacy, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China. Electronic address:
Class I histone deacetylases (HDACs) are closely associated with the development of a diverse array of diseases, including cancer, neurodegenerative disorders, HIV, and inflammatory diseases. Considering the essential roles in tumorigenesis, class I HDACs have emerged as highly desirable targets for therapeutic strategies, particularly in the field of anticancer drug development. However, the conventional class I HDAC inhibitors faced several challenges such as acquired resistance, inherent toxicities, and limited efficacy in inhibiting non-enzymatic functions of HDAC.
View Article and Find Full Text PDFDesign, synthesis, and biological evaluation of RSL3-based GPX4 degraders with hydrophobic tags.
Eur J Med Chem
November 2024
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, Shandong, PR China; Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao, 266237, PR China. Electronic address:
Ferroptosis is a new type of programmed cell death characterized by iron-dependent lipid peroxidation, during which glutathione peroxidase 4 (GPX4) plays an essential role and is well-recognized as a promising therapeutic target for cancer treatment. Although some GPX4 degradation molecules have been developed to induce ferroptosis, the discovery of GPX4 degraders with hydrophobic tagging (HyT) as an innovative approach is more challenging. Herein, we designed and synthesized a series of HyT degraders by linking the GPX4 inhibitor RSL3 with a hydrophobic and bulky group of adamantane.
View Article and Find Full Text PDFSmall molecules targeting HDAC6 for cancer treatment: Current progress and novel strategies.
Biomed Pharmacother
September 2024
Department of Pharmacy, First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, PR China. Electronic address:
Article Synopsis
- * Traditional HDAC6 inhibitors have struggled with limited effectiveness and the ability to bypass HDAC6's other roles, prompting the exploration of novel strategies like dual-acting inhibitors and targeted protein degradation technologies (PROTACs, HyT).
- * Recent advancements in HDAC6 modulator design focus on selective inhibitors and new therapeutic methods, with ongoing discussions about the challenges and future directions for effective cancer therapies targeting HDAC6.
Hydrophobic tagging of small molecules: an overview of the literature and future outlook.
Expert Opin Drug Discov
July 2024
Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan, PR China.
Introduction: Hydrophobic tagging (HyT) technology presents a distinct therapeutic strategy diverging from conventional small molecule drugs, providing an innovative approach to drug design. This review aims to provide an overview of the HyT literature and future outlook to offer guidance for drug design.
Areas Covered: In this review, the authors introduce the composition, mechanisms and advantages of HyT technology, as well as summarize the detailed applications of HyT technology in anti-cancer, neurodegenerative diseases (NDs), autoimmune disorders, cardiovascular diseases (CVDs), and other fields.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!